Physician

Michael A Gelfand, MD

According to 2025 Medicare claims, Michael Gelfand, MD (NPI: 1861706525) practices epileptologists in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN-MEDICAL GROUP (NPI: 1164810271; TIN: 232743545) and primary practice location at 19104-4208.

Gelfand's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 249 traditional Medicare patients, billed 429 HCPCS/CPT codes, and received $36,834 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 1,669 prescription claims across 197 beneficiaries totaling $1,377,669 in drug costs, led by Fintepla (Fenfluramine Hcl). Open Payments data shows 15 records totaling $101,947. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $27,275 to $36,834. In contrast, Part D prescription costs have risen steadily, from $166,313 to $1,377,669. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.